Navigation Links
GlaxoSmithKline to Grant $400,000 to Healthcare Nonprofits at Annual IMPACT Awards

DURHAM, N.C., Oct. 25, 2011 /PRNewswire/ -- GlaxoSmithKline, one of the world's leading research-based pharmaceutical and healthcare companies, today announced the 10 winners of its GlaxoSmithKline IMPACT Awards. In total, the North Carolina and Philadelphia-area healthcare nonprofit organizations will receive $400,000 in grant funding for providing access to healthcare for the underserved in their communities.

Three of the North Carolina recipients listed below are based in counties that became eligible for a GlaxoSmithKline IMPACT Award for the first time in 2011 -- Alamance, Lee and Moore.

"All of the GlaxoSmithKline IMPACT Award winners are leaders in the nonprofit world and in their communities," said Mary Linda Andrews, GlaxoSmithKline Director of Community Partnerships. "The dedicated teams of professionals and volunteers at these organizations are working on the front lines to provide access to healthcare at a time when people need it most. These awards provide additional resources to help them continue their important work."

Grants were awarded to the following organizations:

The Healing Place of Wake County - Raleigh, N.C., Wake County

Helping Hand Clinic Inc. - Sanford, N.C., Lee County

Housing for New Hope, Inc. - Durham, N.C., Durham County

Legal Clinic for the Disabled, Inc. - Philadelphia, Pa.

Moore Free Care Clinic, Inc. - Southern Pines, N.C., Moore County

North Carolina Therapeutic Riding Center, Inc. - Mebane, N.C., Alamance County

Phoenixville Healthcare Access Foundation -  Phoenixville, Pa., Chester County

Senior PharmAssist, Inc. - Durham, N.C., Durham County

Support Center for Child Advocates - Philadelphia, Pa.

Water Street Health Services - Lancaster, Pa., Lancaster County

In North Carolina, GlaxoSmithKline works in partnership with Durham-based Triangle Community Foundation (TCF), a nonprofit that connects resources with needs through community-based philanthropy. TCF and GlaxoSmithKline identified potential nonprofit applicants, encouraged their participation and promoted the awards through grassroots outreach.

"It is essential that nonprofit organizations have the resources they need to address ever-increasing demands for their services, especially in the world of healthcare," said Lori O'Keefe, TCF Vice President for Philanthropic Services and COO. "Our partnership with GlaxoSmithKline highlights the dedication of these nonprofits and will encourage others to participate in the future as we strive toward excellence in healthcare access."

The GlaxoSmithKline IMPACT Awards (whose name represents Innovation, Management, Partnership, Achievement, Community focus and Targeting needs of diverse and underserved populations) honor nonprofit organizations that have a significant impact on their communities and are capable, proactive and effective in their work. This year's winners will receive their GlaxoSmithKline IMPACT Awards at separate ceremonies held at GlaxoSmithKline's headquarters in Research Triangle Park, N.C. and in Philadelphia.

To qualify for a GlaxoSmithKline IMPACT award, organizations must be located in the eligible counties and have a primary mission to provide access to community healthcare services. Each applicant must have annual total operating expenses between $160,000 and $3 million, and have been in existence as a 501(c)(3) nonprofit organization for at least five years.

All organizations are recognized for the success and achievements of their existing overall body of work, not just for new or specific initiatives. A panel of healthcare delivery experts and GlaxoSmithKline representatives determine the winners based on a strong demonstration of ongoing success in providing access to healthcare, commitment to serving people in need, facilitation of healthcare delivery, creative partnerships and policy development, and a solid record of achievement, management and leadership.  

About GlaxoSmithKline

GlaxoSmithKline – one of the world's leading research-based pharmaceutical and healthcare companies – is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For company information, visit GlaxoSmithKline on the World Wide Web at   

About Triangle Community Foundation

Triangle Community Foundation, a nonprofit organization that manages $145 million in funds established by individuals, businesses and families, makes grants to nonprofit organizations and administers a variety of programs for the community's benefit. The Foundation currently manages over 755 funds, ranging in size from $10,000 to $10 million, primarily for the benefit of Wake, Durham, Orange and Chatham counties. During the 2010-11 fiscal year, TCF granted more than $14 million to nonprofits, schools and community efforts. On average, it distributes more than 10% of its assets each year, raising the total value of grants made since the Foundation's inception in 1983 to over $173 million. For more information, please visit

SOURCE GlaxoSmithKline
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. GlaxoSmithKline Donates Scientific Equipment to Advance IDRIs Global Health Mission
2. GlaxoSmithKline CEO and CFO Interviewed on Q2 2011 Results
3. GlaxoSmithKline Receives FDA Approval for BOOSTRIX® to Help Prevent Whooping Cough in Adults 65 Years and Older
4. GlaxoSmithKline Implements Next Phase of New Incentive Compensation Program for U.S. Sales Representatives
5. GlaxoSmithKline Confirms allis Safety Profile
6. Tolerx and GlaxoSmithKline Announce Phase 3 Defend-1 Study of Otelixizumab in Type 1 Diabetes Did Not Meet Its Primary Endpoint
7. GlaxoSmithKline Wins Environmental Stewardship Award
8. GlaxoSmithKline 15th Annual IMPACT Awards Seek Philadelphia Area and Camden Healthcare Nonprofits
9. GlaxoSmithKline Applauds North Carolinas Child Advocates
10. A Statement from GlaxoSmithKline Consumer Healthcare on FDA Regulation of Smokeless Tobacco Products
11. Mylan Granted Temporary Restraining Order Against GlaxoSmithKline and Apotex Prohibiting the Supply, Sale and/or Importing of a Generic Version of Paxil CR
Post Your Comments:
(Date:11/25/2015)... 2015 Endo International plc (NASDAQ: ENDP ) ... President and CEO, will discuss corporate updates at the 27 ... New York on Wednesday, December 2, 2015 at ... Investor Relations, and then the link to the event. Participants ... time to visit the site and download any streaming media ...
(Date:11/25/2015)... November 25, 2015 --> ... blood glucose devices was valued at $11,171.1 million in ... CAGR of 5.7% during 2015 - 2022. The global ... increasing prevalence of diabetes. In addition, the increase in ... also contributing to the growth of the market. Furthermore, ...
(Date:11/25/2015)... 25, 2015  Mindray Medical International ... MR ), a leading developer, manufacturer ... today announced that it will hold ... shareholders at the Company,s Hong Kong office (FLAT/RM ... Edward West Road, Mongkok KL, Hong Kong) ...
Breaking Medicine Technology:
(Date:11/25/2015)... , ... November 25, 2015 , ... The McHenry County ... recent successful appellate decision obtained by Attorneys Francisco J. Botto and Alex C. Wimmer. ... Illinois Workers’ Compensation Comm’n, 2015 IL App (2d) 130884WC. , According to court documents, ...
(Date:11/25/2015)... ... November 25, 2015 , ... SCOTTSDALE, AZ) - Today, ... in both surgical and non-surgical treatments, announced the expansion of his private practice ... Surgery. , Highly trained and nationally recognized for his natural approach, Dr. ...
(Date:11/25/2015)... ... November 25, 2015 , ... In an ongoing Clinical ... Center (RMC) in Chicago, IL, UV Angel is evaluating the efficacy of its product ... intensive care units (totaling 30 beds) from May 2014 through October 2015 at a ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... provide scholarships for people struggling with eating disorders as a result of the ... second annual event, held at Fox Run Golf Club in Eureka, will help ...
(Date:11/25/2015)... ... November 25, 2015 , ... Privately owned Contract ... significant expansion of its current state of the art research, development and manufacturing ... to increase its manufacturing capacity as well as to support its clients’ growing ...
Breaking Medicine News(10 mins):